BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2889260)

  • 1. Famotidine: a notable lack of drug interactions.
    Humphries TJ
    Scand J Gastroenterol Suppl; 1987; 134():55-60. PubMed ID: 2889260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of H2-receptor antagonists on drug interaction in rats.
    Lin JH; Cocchetto DM; Yeh KC; Duggan DE
    Drug Metab Dispos; 1986; 14(6):649-53. PubMed ID: 2877821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of histamine H2-receptor antagonists on the hepatic elimination of drugs].
    Klotz U; Reimann I
    Klin Wochenschr; 1983 Jul; 61(13):625-32. PubMed ID: 6136626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cimetidine, ranitidine and famotidine on rat hepatic microsomal cytochrome P-450 activities.
    Bast A; Smid K; Timmerman H
    Agents Actions; 1989 Apr; 27(1-2):188-91. PubMed ID: 2568738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.
    Powell JR; Donn KH
    J Clin Gastroenterol; 1983; 5 Suppl 1():95-113. PubMed ID: 6140286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of diazepam with famotidine and cimetidine, two H2-receptor antagonists.
    Locniskar A; Greenblatt DJ; Harmatz JS; Zinny MA; Shader RI
    J Clin Pharmacol; 1986 Apr; 26(4):299-303. PubMed ID: 2871051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of nizatidine on drug metabolism.
    Klotz U
    Scand J Gastroenterol Suppl; 1987; 136():18-23. PubMed ID: 2892251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
    Sakaue H; Akamatsu K; Hirabayashi Y; Sasaki T; Nakanishi K; Okada S; Kanaoka M; Nishinobu M; Masumoto S; Ohta Y
    Clin Ther; 1987; 9(6):602-6. PubMed ID: 2894244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of five structurally diverse H2-receptor antagonists on drug metabolism.
    Pasanen M; Arvela P; Pelkonen O; Sotaniemi E; Klotz U
    Biochem Pharmacol; 1986 Dec; 35(24):4457-61. PubMed ID: 2878667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow.
    Sambol NC; Upton RA; Chremos AN; Lin ET; Williams RL
    Br J Clin Pharmacol; 1989 Jan; 27(1):83-7. PubMed ID: 2565119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [H2 antagonists as inhibitors of cytochrome P-450 in rat liver: in vitro and in vivo effects].
    Carrasco M; Gaule C; Vega P; del Villar E
    Rev Med Chil; 1992 May; 120(5):539-44. PubMed ID: 1364175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of famotidine with rat liver microsomes, a study showing less inhibition of drug metabolism than with cimetidine.
    Imai Y; Inada M; Tamura S; Noda S; Kawata S; Minami Y; Tarui S
    Pharmacol Res Commun; 1986 Jul; 18(7):629-38. PubMed ID: 2876442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of famotidine on oxidative drug metabolism.
    Somerville KW; Kitchingman GA; Langman MJ
    Eur J Clin Pharmacol; 1986; 30(3):279-81. PubMed ID: 2874031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.
    Mojaverian P; Rocci ML; Saccar CL; Vlasses PH; Ferguson RK
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):155-9. PubMed ID: 2864251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.
    Humphries TJ
    Dig Dis Sci; 1991 Dec; 36(12):1665-9. PubMed ID: 1748033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of human liver phenacetin O-deethylation by histamine and four histamine H2-receptor antagonists.
    Reilly PE; Mason SR; Gillam EM
    Xenobiotica; 1988 Apr; 18(4):381-7. PubMed ID: 2899931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists.
    Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN
    Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
    Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA
    Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.